Qingya Luo
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer.
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer.
Journal: Cell death and differentiation
Published: January 14, 2026
ALYREF condensation stabilizes m5C-modified PARP10 mRNA and promotes PI3K-AKT signaling in ovarian cancer.
Journal: The EMBO journal
Published: February 27, 2025
SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification.
Journal: Cancer research
Published: November 09, 2024
hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer.
Journal: Nature communications
Published: April 28, 2024
m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation.
Journal: Oncogene
Published: January 10, 2024
The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance.
Journal: Molecular cell
Published: December 23, 2023
RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer.
Journal: Experimental & molecular medicine
Published: June 29, 2023
Upregulation of LRRC8A by m5C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer.
Journal: International journal of biological sciences
Published: September 23, 2022
The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ.
Journal: Molecular therapy. Nucleic acids
Published: May 17, 2021
YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.
Journal: Frontiers in oncology
Published: January 07, 2021
Knockdown of YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) inhibits cell proliferation and promotes apoptosis in cervical cancer cells
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: May 12, 2020
PHLDA1 Modulates the Endoplasmic Reticulum Stress Response and is required for Resistance to Oxidative Stress-induced Cell Death in Human Ovarian Cancer Cells.
Journal: Journal of Cancer
Published: February 24, 2020
Last Updated: 09/26/2026